Ultragenyx Pharmaceutical RARE Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Ultragenyx Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ultragenyx Pharmaceutical's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ultragenyx Pharmaceutical's total current assets?
- Ultragenyx Pharmaceutical (RARE) reported total current assets of $657M in Q1 2026.
- How has Ultragenyx Pharmaceutical's total current assets changed year-over-year?
- Ultragenyx Pharmaceutical's total current assets decreased by 6.0% year-over-year, from $699.16M to $657M.
- What is the long-term trend for Ultragenyx Pharmaceutical's total current assets?
- Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's total current assets has grown at a -6.0% compound annual growth rate (CAGR), from $1.3B to $951M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.